{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:29:31Z","timestamp":1788866971365,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40911"],"award-info":[{"award-number":["2023JJ40911"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304636"],"award-info":[{"award-number":["82304636"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Polymyxins have re\u2010emerged as a last\u2010resort therapeutic option for infections caused by carbapenem\u2010resistant gram\u2010negative bacteria. Nephrotoxicity induced by polymyxins is a significant limitation of its use in the clinic. Polymyxin B and colistin sulfate are two widely used active formulations of polymyxins. However, there is a lack of studies conducting a comparative assessment of nephrotoxicity between the two formulations. This study aimed to compare the nephrotoxicity of polymyxin B and colistin sulfate in critically ill patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cohort study among critically ill patients who received intravenous polymyxin B or colistin sulfate for over 48\u2009h from January 2017 to January 2024. The primary outcome was the incidence of acute kidney injury (AKI) associated with polymyxins, and the secondary outcome was 30\u2010day all\u2010cause mortality. Additionally, the risk factors of polymyxins\u2010induced AKI and 30\u2010day all\u2010cause mortality were identified by Cox proportional hazard regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 473 patients were included in this study. The overall incidence of AKI was significantly higher in patients who received polymyxin B compared to those who received colistin sulfate in the unmatched cohort (20.8% vs. 9.0%, <jats:italic>p\u2009=<\/jats:italic>\u20090.002) and in the propensity score matching cohort (21.1% vs. 7.0%, <jats:italic>p\u2009=<\/jats:italic>\u20090.004), respectively. However, there was no significant difference in 30\u2010day all\u2010cause mortality between the two groups. Polymyxin type, septic shock, and concomitant use of vasopressors were identified as independent risk factors for polymyxin\u2010induced AKI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The prevalence of AKI was higher among patients who received polymyxin B compared to those treated with colistin sulfate. However, there was no significant difference in 30\u2010day all\u2010cause mortality between the two groups. Further prospective, multicenter studies with larger sample sizes are needed to validate these findings.<\/jats:p><\/jats:sec>","DOI":"10.1002\/phar.4601","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T08:38:08Z","timestamp":1721810288000},"page":"631-641","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Acute kidney injury with intravenous colistin sulfate compared with polymyxin B in critically ill patients: A real\u2010world, retrospective cohort study"],"prefix":"10.1002","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8000-1992","authenticated-orcid":false,"given":"Qin\u2010jie","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pharmacy The Third Xiangya Hospital of Central South University  Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi\u2010xiao","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy The Third Xiangya Hospital of Central South University  Changsha Hunan China"},{"name":"College of Pharmacy Zunyi Medical University  Zunyi Guizhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0215-3919","authenticated-orcid":false,"given":"Mong\u2010hsiu","family":"Song","sequence":"additional","affiliation":[{"name":"Xiangya School of Pharmaceutical Sciences Central South University  Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien\u2010yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Xiangya School of Pharmaceutical Sciences Central South University  Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun\u2010hao","family":"Liang","sequence":"additional","affiliation":[{"name":"Xiangya School of Pharmaceutical Sciences Central South University  Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-8722","authenticated-orcid":false,"given":"Yue\u2010liang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy The Third Xiangya Hospital of Central South University  Changsha Hunan China"},{"name":"Department of Pharmacy and Center of Clinical Pharmacology, The Third Xiangya Hospital Central South University  Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010cong","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy The Third Xiangya Hospital of Central South University  Changsha Hunan China"},{"name":"Department of Pharmacy and Center of Clinical Pharmacology, The Third Xiangya Hospital Central South University  Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2209"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1086\/429323"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.915958"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.967412"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8010031"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2710-4"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i31.11466"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00873-8"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2018.11.008"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.12.009"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081317"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-018-0262-0"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit453"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02634-15"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1067548"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-23-336"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00909-8"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08339-0"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107031"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3934-7"},{"issue":"10","key":"e_1_2_11_22_1","first-page":"1194","article-title":"Chinese expert consensus on polymyxins in the clinical practice","volume":"31","author":"Chinese Research Hospital Association Of Critical Care M, Chinese Research Hospital Association Of Evidence B, Translational Infectious Diseases","year":"2019","journal-title":"Zhonghua wei zhong bing ji jiu yi xue"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.5.5.811"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc2872"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1018"},{"issue":"1","key":"e_1_2_11_26_1","first-page":"15","article-title":"Polymyxin B for gram negative multidrug resistant bacteria in a Hispanic population","volume":"38","author":"De Le\u00f3n\u2010Borr\u00e1s R","year":"2019","journal-title":"P R Health Sci J"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105328"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-4959"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00006-08"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02690-16"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00835-21"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-021-00977-w"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7795096"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107035"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2023.11.054"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001198"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107204"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2021.08.011"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir611"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.4601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:20:28Z","timestamp":1761060028000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.4601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1002\/phar.4601"],"URL":"https:\/\/doi.org\/10.1002\/phar.4601","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"2024-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}